Psychedelics Today4 Jun 2024

PT518 – The EMBARK Model of Psychedelic Therapy, with Alex Belser, Ph.D. & Bill Brennan, Ph.D.

In this episode, Kyle interviews Alex Belser, Ph.D. and Bill Brennan, Ph.D.: psychologists, psychedelic researchers, authors, and co-creators of the EMBARK model, a framework for psychedelic therapy.

When Belser and Brennan worked together at Cybin, they canvassed the field of psychedelic research and saw very little reporting (if any) of the manuals researchers were using, so they created the EMBARK model as a "big tent" framework – a way to understand what patients were going through from the perspective of six different clinical domains, where the clinician can go deeper into whichever domain is needed based on their specific skill sets. The EMBARK model has been used in two randomized controlled trials to date, and its corresponding book, EMBARK Psychedelic Therapy for Depression: A New Approach for the Whole Person (co-authored by Belser and Brennan), was released in April.

They discuss:

The six domains and four ethical care cornerstones that make up EMBARK, as well as the many proposed change mechanisms that come into play
Concerns over facilitators stepping aside and letting the medicine do the work: How much of a factor is someone's presence in the room?
How much smaller, "little t" traumas can affect people – trauma doesn't always come from a single hallmark event
The need for facilitators to be trained well (and trauma-informed), as it's nearly impossible to tell when an adverse outcome is coming

and more!

For links, head to the show notes page.

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(774)

PT 616 - Karina Bashir on Psychedelics, Islam, and Human Rights

In this engaging episode of the Psychedelics Today podcast, host Joe Moore sits down with Karina Bashir, an attorney working at the intersection of law, business ethics, and psychedelics. Karina, of c...

22 Jul 20251h 5min

PT 615 - Kristen Nash and Erica Siegel on Risk Reduction and Psychedelic Safety

In this deeply important episode of Psychedelics Today, Joe Moore is joined by Kristen Nash, MPH, and returning guest Erica Siegel, LCSW, for a nuanced conversation about risk reduction, harm preventi...

18 Jul 20251h 21min

PT 614 - Erica Rex: Scientific Integrity, Psychedelic Research, and the Religious Leader Study

In this episode, Joe Moore speaks with award-winning science journalist Erica Rex about her personal experience participating in psychedelic research, her upcoming book Seeing What Is There: My Search...

15 Jul 20251h 19min

PT 613 - Daniel Pinchbeck - From Cultural Catalyst to Capitalist Co-optation: Reflections on Psychedelic Science, AI, and Idealist Monism

In this expansive episode of Psychedelics Today, Joe Moore sits down with author and cultural theorist Daniel Pinchbeck to explore the evolving—and increasingly contested—role of psychedelics in socie...

8 Jul 20251h 9min

PT 612 - Mattha Busby: Power, Pleasure, and the Psychedelic Movement's Reckoning

In this wide-ranging conversation, journalist Mattha Busby joins Joe Moore to reflect on the shifting tone of the psychedelic movement in the wake of Psychedelic Science 2025. Based in Vancouver, Matt...

3 Jul 20251h 16min

PT 611 - Dylan Beynon - Mindbloom

Dylan Beynon: At-Home Ketamine Therapy, Big Pharma Pushback, and the Future of Psychedelic Accessibility In this episode, Joe Moore welcomes Dylan Beynon, CEO and Founder of Mindbloom, one of the larg...

1 Jul 20251h 33min

PT 610 - Victoria Litman - The Future of Psychedelic Regulation Is Local

In this episode, we sit down with Victoria Litman, M.Div., J.D., LL.M., to discuss why the future of psychedelic access in the United States is being shaped not by federal agencies, but by the bold ac...

27 Jun 202554min